
Do spiroindolines have the potential to replace vesamicol as lead compound for the development of radioligands targeting the vesicular acetylcholine transporter?
Keywords: YBQFMGUWXJJOBE-OWOJBTEDSA-N; UJLKLUQGBGSJOO-OWOJBTEDSA-N; DSSGEOKNTGYRDY-OWOJBTEDSA-N; RDXPBCTWNYFBFI-OWOJBTEDSA-N; MTENKAMVZFIDIJ-OWOJBTEDSA-N; WLWBMTWWXNCMJH-OWOJBTEDSA-N; VAChT; Vesamicol; Spiroindolines; PET; Sigma receptors;